Rite Aid Corporation, a prominent American drugstore chain, is contemplating shuttering 400 to 500 outlets amidst bankruptcy deliberations. While talks are ongoing, the company's massive $3.3 billion debt looms large. Concurrently, federal lawsuits and a DOJ action over alleged mishandling of opioid prescriptions challenge the pharmacy's operations.
Currently, Rite Aid is negotiating the terms of a bankruptcy plan, which may result in the permanent closure of its stores, now numbering more than 2,100 in the 17 U.S. states. It was reported that some individuals familiar with the ongoing talks with creditors told the Wall Street Journal that the company suggested closing up to 500 pharmacies in bankruptcy.
It was also said that Rite Aid also proposed to either sell or allow creditors to take over the remaining drug stores. As per Fox Business, there is one group of bondholders that prefers to liquidate a greater number of stores, and officials are said to be discussing the exact number.
But while there is an ongoing talk, Rite Aid said they have not yet made any decision. It was already reported that the drugstore chain is planning to file for bankruptcy protection due to the more than $3.3 billion debt it has incurred. It also faces thousands of federal lawsuits about its alleged part in the sweeping spread of opioids.
Washington Examiner reported that Rite Aid is also being confronted by huge pressure from the U.S. Department of Justice, which filed a lawsuit against the company for allegedly "knowingly" filling up unlawful prescriptions for controlled substances. The DOJ said the pharmacy giant missed "obvious red flags" that the medications it sold were being abused by customers such as medical fentanyl and oxycodone.
Rite Aid disagreed with how the government described its handling of opioid medications. It also denied the claims it is filling illegal prescriptions.
Photo by: Chance Pereira/Flickr(CC BY-SA 2.0)


India Services Sector Rebounds in January as New Business Gains Momentum: HSBC PMI Shows Growth
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
South Korea Inflation Hits Five-Month Low as CPI Reaches Central Bank Target
Japan Finance Minister Defends PM Takaichi’s Remarks on Weak Yen Benefits
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Taiwan Urges Stronger Trade Ties With Fellow Democracies, Rejects Economic Dependence on China
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
China Services PMI Hits Three-Month High as New Orders and Hiring Improve
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast 



